Verition Fund Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-23,927
| Closed | -$73.9K | – | 2438 |
|
|
2024
Q2 | $73.9K | Buy |
+23,927
| New | +$73.9K | ﹤0.01% | 2111 |
|
|
2023
Q2 | – | Sell |
-25,371
| Closed | -$76.9K | – | 1878 |
|
|
2023
Q1 | $76.9K | Buy |
+25,371
| New | +$76.9K | ﹤0.01% | 1759 |
|
|
2022
Q4 | – | Sell |
-11,011
| Closed | -$21K | – | 1652 |
|
|
2022
Q3 | $21K | Buy |
11,011
+600
| +6% | +$1.14K | ﹤0.01% | 2172 |
|
|
2022
Q2 | $28K | Buy |
+10,411
| New | +$28K | ﹤0.01% | 2107 |
|
|
2020
Q1 | – | Sell |
-174,455
| Closed | -$485K | – | 486 |
|
|
2019
Q4 | $485K | Buy |
+174,455
| New | +$485K | 0.01% | 576 |
|